your badges 52W Range $49–$124 3% of range Analyst Rating STRONG BUY 7 analysts Price Target $146 +187% upside P/E · ROE -27.9% Net Profit Margin ·

DRUG Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $50.69
EPS $-0.65
ROE -27.9%
52W Range $49–$124

DRUG Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
July 14, 2023 1-for-5 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-0.65
2020-09-30 → 2024-09-30
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

No data for this ratio group yet

Not enough fundamentals data to compute this ratio group yet.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 9
Metric Trend 20252024202320222021
R&D Expense $11M$1M$5M$12M$6M
SG&A Expense $784.1K$264.0K$278.8K$478.2K$197.1K
Interest Income $2M$30.1K$0$0·
Income Tax $0$0$0$0$0
Net Income $-12M$-3M$-7M$-15M$-9M
EPS (Basic) $-1.78$-0.65$-1.98$-6.06$-4.82
EPS (Diluted) ·$-0.65$-1.98$-6.06$-4.82
Shares (Basic) 6,878,0514,310,1683,719,7752,470,3831,794,805
Shares (Diluted) ·4,310,1683,719,7752,470,3831,794,805
Balance Sheet 8
Metric Trend 20252024202320222021
Cash & Equivalents $55M$6M$7M$12M$20M
Current Assets $84M$6M$7M$12M$20M
Total Assets $84M$6M$7M$12M$20M
Accounts Payable $2M$449.3K$207.3K$1M$638.6K
Current Liabilities $781.2K$528.7K$280.9K$1M$638.6K
Total Liabilities $2M$568.3K$280.9K$2M$638.6K
Retained Earnings $-47M$-34M$-32M$-24M$-9M
Stockholders' Equity $82M$6M$7M$11M$19M
Cash Flow 2
Metric Trend 20252024202320222021
Operating Cash Flow $-9M$-2M$-7M$-14M$-7M
Financing Cash Flow $86M$810.6K$2M$5M$26M
Profitability 2
Metric Trend 20252024202320222021
ROA -27.0%-43.2%-77.7%-93.2%·
ROE -27.9%-46.2%-86.0%-100.0%·
Liquidity & Solvency 2
Metric Trend 20252024202320222021
Current Ratio 107.911.324.38.1·
Quick Ratio 70.910.824.07.9·
Per Share 2
Metric Trend 20252024202320222021
Cash Flow / Share ·$-0.43$-1.89··
EPS (TTM) ·$-0.65$-1.98$-6.06·
Valuation (TTM) 3
Metric Trend 20252024202320222021
Net Income TTM $-12M$-3M$-7M$-15M·
P/E ·-1.8-0.8-1.0·
Earnings Yield ·-55.6%-123.8%-98.5%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-09-302024-09-302023-09-302022-09-302021-09-30
Net Income $-12M $-3M $-7M $-15M $-9M
Diluted EPS · $-0.65 $-1.98 $-6.06 $-4.82

Institutional owners (13F) 101 filers · $655.8M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 101
Value held $655.8M
New positions 20
Exited positions 12
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
20 (-8 vs prior Q) 12 (+5 vs prior Q) 47 (+3 vs prior Q) 15 (0 vs prior Q) -1.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
JANUS HENDERSON GROUP PLC $93,518,052 1,284,324 14.26% Shares
Cormorant Asset Management, LP $63,180,000 900,000 9.63% Shares
BlackRock, Inc. $48,170,117 686,184 7.34% Shares
Vivo Capital, LLC $39,113,474 557,172 5.96% Shares
Vestal Point Capital, LP $38,259,000 545,000 5.83% Shares
BRAIDWELL LP $33,964,304 483,822 5.18% Shares
Driehaus Capital Management LLC $30,423,065 433,377 4.64% Shares
Balyasny Asset Management L.P. $24,222,721 345,053 3.69% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $23,517,000 335,000 3.59% Shares
Point72 Asset Management, L.P. $22,984,603 327,416 3.50% Shares
DEERFIELD MANAGEMENT COMPANY, L.P. $19,866,600 283,000 3.03% Shares
RA CAPITAL MANAGEMENT, L.P. $18,603,000 265,000 2.84% Shares
Parkman Healthcare Partners LLC $14,394,721 205,053 2.19% Shares
MPM BIOIMPACT LLC $14,188,403 202,114 2.16% Shares
WELLINGTON MANAGEMENT GROUP LLP $12,026,312 171,315 1.83% Shares
GOLDMAN SACHS GROUP INC $9,384,968 133,689 1.43% Shares
EVENTIDE ASSET MANAGEMENT, LLC $9,126,913 130,013 1.39% Shares
STATE STREET CORP $8,576,896 122,178 1.31% Shares
SEVEN GRAND MANAGERS, LLC $8,424,000 120,000 1.28% Shares
GREAT POINT PARTNERS LLC $7,694,131 109,603 1.17% Shares
GEODE CAPITAL MANAGEMENT, LLC $7,311,049 104,146 1.11% Shares
ORBIMED ADVISORS LLC $6,528,600 93,000 1.00% Shares
ACUTA CAPITAL PARTNERS, LLC $6,510,699 92,745 0.99% Shares
Ikarian Capital, LLC $6,244,361 88,951 0.95% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $5,620,212 80,060 0.86% Shares
Sio Capital Management, LLC $5,191,430 73,952 0.79% Shares
Trexquant Investment LP $4,957,173 70,615 0.76% Shares
B Group, Inc. $4,738,500 67,500 0.72% Shares
MILLENNIUM MANAGEMENT LLC $4,685,148 66,740 0.71% Shares
CITADEL ADVISORS LLC $4,670,616 66,533 0.71% Shares
Schonfeld Strategic Advisors LLC $4,652,645 66,277 0.71% Shares
Walleye Capital LLC $4,640,641 66,106 0.71% Shares
VANGUARD GROUP INC $3,790,871 48,576 0.58% Shares
Woodline Partners LP $3,205,894 45,668 0.49% Shares
NORTHERN TRUST CORP $2,981,114 42,466 0.45% Shares
Artia Global Partners LP $2,696,171 38,407 0.41% Shares
AMERIPRISE FINANCIAL INC $2,660,720 37,902 0.41% Shares
LOS ANGELES CAPITAL MANAGEMENT LLC $2,509,440 35,747 0.38% Shares
KVP Capital Advisors, LP $2,233,273 31,813 0.34% Shares
SUPERSTRING CAPITAL MANAGEMENT LP $2,138,011 30,456 0.33% Shares
ADAR1 Capital Management, LLC $2,127,060 30,300 0.32% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,956,474 27,870 0.30% Shares
BANK OF AMERICA CORP /DE/ $1,893,013 26,966 0.29% Shares
AdvisorShares Investments LLC $1,704,035 24,274 0.26% Shares
Aquatic Capital Management LLC $1,462,336 20,831 0.22% Shares
PLATINUM INVESTMENT MANAGEMENT LTD $1,342,715 19,127 0.20% Shares
MORGAN STANLEY $1,305,698 18,599 0.20% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1,265,846 18,032 0.19% Shares
Nuveen, LLC $1,185,608 16,889 0.18% Shares
UBS Group AG $1,090,627 15,536 0.17% Shares

Show all 101 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Ian McDonald ×6 filings July 2, 2026 13.70% Amendment · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 10 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IBRN · iShares Trust 0.52% 593 SH Sept. 11, 2026 Daily
IWC · iShares Trust 0.11% 25,125 SH Sept. 11, 2026 Daily
VFMO · VANGUARD WELLINGTON FUND 0.10% 28,882 SH Aug. 19, 2026 Daily
IWO · iShares Trust 0.03% 69,591 SH Sept. 11, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.03% 7,942 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.02% 42,649 SH Aug. 19, 2026 Daily
RSSL · Global X Funds 0.02% 3,553 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.02% 190,882 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 2,021 SH Sept. 10, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 587 SH Aug. 19, 2026 Daily

DRUG Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts BUY
Median target $140.91 +178.0%
3 42.9% Strong Buy
3 42.9% Buy
1 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

4 analysts · 2026-10-03

Mean target $145.60 +187.2%

← Below all targets Current price $50.69
Low$81.36 Mean$145.60 High$219.22

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
DRUG · · · · -27.9% ·
OLMA $2.03B -13.4 · · -39.4% ·
FTH · · · · · ·
IMMX $277M -5.9 · · -59.8% ·
NVCT $194M -5.7 · · -149.9% ·
STTK $231M -5.2 -82.5% -4880.9% -70.0% ·
MDXG $1.00B 21.2 20.0% 11.6% 20.5% 82.6%
AURA $347M -3.1 -29.7% -1601.4% -68.2% ·
CLYM $191M -4.5 · · -34.6% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 40-F filed Dec 23, 2025